BRCTF (BioArctic AB) Total Stockholders Equity : $190.9 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is BioArctic AB Total Stockholders Equity?

BioArctic AB's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $190.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. BioArctic AB's Book Value per Share for the quarter that ended in Mar. 2025 was $2.16. The ratio of a company's debt over equity can be used to measure how leveraged this company is. BioArctic AB's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.03.

BioArctic AB Total Stockholders Equity Historical Data

The historical data trend for BioArctic AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioArctic AB Total Stockholders Equity Chart

BioArctic AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

108.49

86.77

75.76

102.03

81.47

BioArctic AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															95.35	88.62	89.81	81.47	190.86

BioArctic AB (OTCPK:BRCTF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

BioArctic AB's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(190.862	-	0)	/	88.528
	=	2.16

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

BioArctic AB's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.314	+	3.719)	/	190.862
	=	0.03

BioArctic AB Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of BioArctic AB's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BioArctic AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (OTCPK:BRCTF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

BIOA B:Sweden BIOABs:UK 0RV2:UK B9A:Germany

Address

Warfvinges vag 35, Stockholm, SWE, SE-112 51

Website

https://www.bioarctic.se

BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.